Tevos Pharmaceuticals Llp - Company Profile

It is a pharma limited liability partnership based in Ahmedabad, Gujarat, India, established in 2020.
2020 Ahmedabad, Gujarat, India Active
Last Updated:
Access Report
About Tevos Pharmaceuticals Llp

Tevos Pharmaceuticals Llp, a active limited liability partnership, was established on 13 February 2020 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the pharma sector, it holds LLPIN: AAR-9087. Registered under ROC Roc Ahmedabad. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Mrugank Jatin Shah (Designated Partner), Haresh Sevantilal Shah (Designated Partner), Jatin Sevantilal Shah (Designated Partner). Its latest date of accounts and solvency statement 31 March 2023. It is based at 108A, Raghuvir Estate, N.H. 8, At. Aslali, Ahmedabad, Gujarat, 382427.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAR-9087

  • Incorporation Date

    13 February 2020

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Ahmedabad

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 6 Year,
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth **** %
  • Total Assets -15.80%
Company report

Tevos Pharmaceuticals Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Tevos Pharmaceuticals Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Tevos Pharmaceuticals Llp?
Current Designated Partners
Name Designation Appointment Date Status
Mrugank Jatin Shah Designated Partner 13 Feb 2020 Current
Haresh Sevantilal Shah Designated Partner 13 Feb 2020 Current
Jatin Sevantilal Shah Designated Partner 13 Feb 2020 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Tevos Pharmaceuticals Llp.

Tevos Pharmaceuticals Llp, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Tevos Pharmaceuticals Llp revenue growth over time
Tevos Pharmaceuticals Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -15.80%
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Tevos Pharmaceuticals Llp?

Unlock access to Tevos Pharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Tevos Pharmaceuticals Llp?

Unlock and access historical data on people associated with Tevos Pharmaceuticals Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Tevos Pharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tevos Pharmaceuticals Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Tevos Pharmaceuticals Llp
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Tevos Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2024 as per latest MCA records. was documented.

  • Statement of Assets & Liabilities

    The activity Tevos Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ahmedabad. was completed.

  • Director Appointment

    The activity Mrugank Jatin Shah was appointed as a Designated Partner was appointed as a Designated Partner on 13 Feb 2020 & has been associated with this company since 6 years . was completed.

  • Director Appointment

    Progress on Haresh Sevantilal Shah was appointed as a Designated Partner was appointed as a Designated Partner on 13 Feb 2020 & has been associated with this company since 6 years . was documented.

  • Director Appointment

    Progress on Jatin Sevantilal Shah was appointed as a Designated Partner was appointed as a Designated Partner on 13 Feb 2020 & has been associated with this company since 6 years . was documented.

  • LLP Incorporation

    The activity Tevos Pharmaceuticals Llp was registered on 13 Feb 2020 with Roc Ahmedabad & aged 6 years as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Tevos Pharmaceuticals Llp?

The LLPIN of Tevos Pharmaceuticals Llp is AAR-9087.

Where is Tevos Pharmaceuticals Llp headquartered?

Tevos Pharmaceuticals Llp is headquartered at 108A, Raghuvir Estate, N.H. 8, At. Aslali, Ahmedabad, Gujarat, 382427.

When was Tevos Pharmaceuticals Llp incorporated?

Tevos Pharmaceuticals Llp was incorporated on 13 February 2020.

Who are the current directors of Tevos Pharmaceuticals Llp?

The current directors of Tevos Pharmaceuticals Llp are

What is the primary industry of Tevos Pharmaceuticals Llp?

The primary industry of Tevos Pharmaceuticals Llp is Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available